Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDabak, Murat
dc.contributor.authorDabak, Durrin O.
dc.contributor.authorKuloğlu, Tuncay
dc.contributor.authorBaydar, Ersoy
dc.contributor.authorBulut, Hakan
dc.contributor.authorÖzöner, Özgür
dc.date.accessioned2022-05-11T14:42:22Z
dc.date.available2022-05-11T14:42:22Z
dc.date.issued2020
dc.identifier.issn1871-5303
dc.identifier.issn2212-3873
dc.identifier.urihttps://doi.org/10.2174/1871530320666200530222426
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9349
dc.description.abstractBackground: Extrarenal 1 alpha,25-dihydroxyvitamin D-3 (1,25-D) locally produced by immune cells plays crucial roles in the regulation of the immune system. However, in vivo status of extrarenal 1,25-D and 25-hydroxyvitamin D (25-D) in acute inflammatory conditions are unknown. Objective: The aim of this study was to determine the extrarenal 1,25-D level in circulation in bilaterally nephrectomized rats, induced by low-dose lipopolysaccharide (LPS). Methods: Renal 1,25-D synthesis was terminated through bilateral nephrectomy in rats. The rats received intraperitoneal LPS (50 mu g/kg BW) three times and the experiment was ended 24 hours after nephrectomy. Serum 1,25-D, 25-D, calcium, phosphorus, intact parathyroid hormone, and calcitonin levels were measured and immunohistochemistry was applied to detect the sources of extrarenal 1,25-D synthesis. Results: Circulatory 1,25-D concentration remarkably increased in both LPS-treated and non-treated bilaterally nephrectomized rats. Elevated circulatory 1,25-D did not have hypercalcemic endocrinal effects. The increased 1,25-D level also resulted in a concurrent rapid and dramatic depletion of circulatory 25-D. Conclusion: Extrarenal 1,25-D could enter into the systemic circulation and, therefore, might have systemic effects besides its autocrine and paracrine functions.en_US
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [2140681]en_US
dc.description.sponsorshipThis work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (Project Number: 2140681).en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ Ltden_US
dc.identifier.doi10.2174/1871530320666200530222426
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject1 alpha,25-dihydroxyvitamin D-3en_US
dc.subject25-hydroxyvitamin Den_US
dc.subjectinflammationen_US
dc.subjectextrarenalen_US
dc.subjectanephricen_US
dc.subjectraten_US
dc.subjectCultured Alveolar Macrophagesen_US
dc.subject1,25-Dihydroxyvitamin-D3 Productionen_US
dc.subjectSkeletal Resistanceen_US
dc.subjectParathyroid-Hormoneen_US
dc.subjectVitamin-D3en_US
dc.subjectExpressionen_US
dc.subjectReceptorsen_US
dc.subjectPharmacokineticsen_US
dc.subjectIdentificationen_US
dc.subjectMetabolitesen_US
dc.titleIncreased Circulatory Extrarenal 1 alpha,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Ratsen_US
dc.typearticleen_US
dc.relation.ispartofEndocrine Metabolic & Immune Disorders-Drug Targetsen_US
dc.departmentFakülteler, Veteriner Fakültesi, Klinik Öncesi Bilimler Bölümü, Viroloji Ana Bilim Dalıen_US
dc.authorid0000-0001-7354-0655
dc.authorid0000-0002-5184-6087
dc.identifier.volume20en_US
dc.identifier.issue9en_US
dc.identifier.startpage1523en_US
dc.identifier.endpage1530en_US
dc.institutionauthorBulut, Hakan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6602159436
dc.authorscopusid6506500938
dc.authorscopusid24778581400
dc.authorscopusid52863212500
dc.authorscopusid7003605484
dc.authorscopusid57219317836
dc.authorwosidÖzöner, Özgür/AAD-3691-2021
dc.authorwosidDABAK, MURAT/W-4245-2018
dc.identifier.wosWOS:000587329600017en_US
dc.identifier.scopus2-s2.0-85092184002en_US
dc.identifier.pmid32473004en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster